Abstract
Elastography is a medical technique used to study the elastic properties and stiffness of the muscles. Its main purpose is to find whether tissue is hard or soft to get the diagnostic information about the occurrence or status of a disease. The most widely used techniques are magnetic resonance imaging (MRI) or ultrasound, to create both an anatomical image and the stiffness map for comparison. The increasing incidences of breast and liver cancer, the growing use of advanced diagnosis technique in cancer treatment, rising investments made in research funding, and rapidly developing diagnostic facilities are driving the elastography imaging market globally.
Rising prevalence of different types of cancers and chronic diseases and increasing preference for minimally invasive procedures for cancer diagnosis and treatment are fuelling the elastography imaging market. Technological advancements witnessed in the medical industry and a growing number of government initiatives to fund cancer research are also contributing to this global market’s growth. Increasing prevalence of cancer and other chronic diseases has led to the elevated demand for elastography imaging techniques with high-content screening techniques for diagnosis and treatment. However, the high cost of elastography imaging systems and unfavorable reimbursement scenario may restrain the elastography imaging market. Alternatively, the use of elastography imaging for cancer research is anticipated to generate new growth opportunities in the elastography imaging market over the forecast time period.
The elastography imaging market is categorized on the basis of modality, application, and end-user. By modality, the market is categorized into ultrasound and magnetic resonance elastography. The ultrasound segment held the largest market share in 2018, owing to its quick procedure, low-cost technique, and easy availability.
By application, the market includes radiology, cardiology, OB/GYN, vascular, orthopedic, and musculoskeletal. The radiology segment accounted for the largest share in 2018, due to its wide utilization in the diagnosis and treatment of various diseases like cancer, soft tissue, and abdominal injuries.
By end-user, the elastography imaging market includes diagnostic laboratories, hospitals, ambulatory surgical centers, and clinics. Hospitals and diagnostic laboratories accounted for the largest market shares in 2018, due to the increasing focus on MRI-based elastography imaging and ultrasound.
Europe is expected to dominate the elastography imaging market globally over the forecast time period, owing to the growing investments made by the regional governments in research facilities, ongoing research on cancer, commercialization of elastography imaging, and rising cancer cases. North America held the second spot of the elastography imaging market, due to the increasing chronic diseases and cancer incidences. The Asia Pacific is an emerging market for elastography imaging. China dominated this regional market due to increasing cancer prevalence and rising demand for its detection techniques.
Some key players operating in the elastography imaging market are GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical System, Samsung Medison, Hitachi, Shenzhen Mindray Bio-Medical Electronics, FUJIFILM Holdings, Esaote, SuperSonic Imagine, and Resoundant.
This report segments the global elastography imaging market into:
Global Elastography Imaging Market: By Modality
Magnetic Resonance Elastography
Ultrasound
Global Elastography Imaging Market: By Application
Cardiology
Radiology
Vascular
OB/GYN
Orthopedic
Musculoskeletal
Global Elastography Imaging Market: By End-User
Hospitals
Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers
Global Elastography Imaging Market: By Region
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa